Efficacy of Continuous Skin to Skin Care (Technique Kangaroo: TK) After Birth for Low Birth Weight (LBW) Infants and Their Mothers in Developing Countries (EtudeTK)

December 8, 2011 updated by: Shuko Nagai, Foundation for Advanced Studies on International Development

Randomized Controlled Trial of Continuous Skin to Skin Care (Technique Kangourou: TK) for Low Birth Weight (LBW) Infants and Their Mothers at University Hospital Center of Mahajanga (Centre Hospitalier Universitaire de Mahajanga: CHUM), Madagascar

The purpose of this study is to examine the efficacy of Technique Kangourou (TK) between low birth weight (LBW) infants and their mothers started as soon as possible within 24 hours after birth in developing country.

For the purpose of this study, TK is defined as skin-to-skin direct and continuous (24 hours) contact between LBW infants and their mothers or any other people who substitute mothers.

Study Overview

Study Type

Interventional

Enrollment (Actual)

73

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Mahajanga, Madagascar
        • University Hospital Center of Mahajanga (Centre Hospitalier Universitaire de Mahajanga: CHUM),

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 1 day (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Birth weight (BW) < 2500g
  • Delivery at maternity of CHUM (Birth < 24 hours)
  • Without serious congenital malformation
  • Sat O2 >=95%, HR > 100 / min, RR < 60 / min, Capillary refilling time < 3 sec
  • The mother and the family are motivated to practice TK.
  • The mother and the family available to practise TK should be healthy.

Exclusion Criteria:

  • Apnea of prematurity >20 sec
  • With intravenous infusion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: B
Start conventional care (At first use incubator, and start TK when the infants and mother are completely settled and ready)
Experimental: A
Start TK as soon as possible within 24 hours after birth

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Mortality within 28 days after birth
Time Frame: within 28 days after birth
within 28 days after birth

Secondary Outcome Measures

Outcome Measure
Time Frame
Mobility within 28 days after birth
Time Frame: within 28 days after birth
within 28 days after birth
Mortality and Mobility within 28 days after birth
Time Frame: within 28 days after birth
within 28 days after birth
Difference of (Baby's) loss in weight within 2 days
Time Frame: within 2 days
within 2 days
Difference of (Baby's) Body weight of 14th day after birth
Time Frame: 14th day after birth
14th day after birth
Difference of (Baby's) Body weight of 28th day after birth
Time Frame: 28th day after birth
28th day after birth
Incidence of hypothermia during hospitalisation and (or) during outpatient department (lower than 35.5℃)
Time Frame: Within 28 days after birth
Within 28 days after birth
Incidence of bradycardia or tachycardia during hospitalisation (HR <100, or>180 /min)
Time Frame: within 28 days after birth
within 28 days after birth
Incidence of apnea during hospitalisation (> 20 sec)
Time Frame: within 28 days after birth
within 28 days after birth
Incidence of desaturation during hospitalisation ( <87%)
Time Frame: within 28 days after birth
within 28 days after birth
Length of hospitalisation
Time Frame: within 28 days after birth
within 28 days after birth
Discharge within 7days after birth
Time Frame: within 7days after birth
within 7days after birth
Mobility within 6 months or 1 year after birth
Time Frame: within 6 months or 1 year
within 6 months or 1 year
Mortality and Morbility within 6 months or 1 year after birth
Time Frame: within 6 months or 1 year
within 6 months or 1 year
Mortality within 6 months or 1 year after birth
Time Frame: within 6 months or 1 year
within 6 months or 1 year
Incidence of hyperthermia during hospitalisation and (or) outpatient department (upper than 37.5℃)
Time Frame: Within 28 days after birth
Within 28 days after birth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Shuko Nagai, MD, Groupe d'Etude de la Technique Kangourouà Mahajanga, Madagascar

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2007

Primary Completion (Actual)

September 1, 2008

Study Completion (Actual)

March 1, 2009

Study Registration Dates

First Submitted

September 17, 2007

First Submitted That Met QC Criteria

September 17, 2007

First Posted (Estimate)

September 18, 2007

Study Record Updates

Last Update Posted (Estimate)

December 12, 2011

Last Update Submitted That Met QC Criteria

December 8, 2011

Last Verified

December 1, 2011

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Birth Weight

Clinical Trials on TK as soon as possible within 24 hours after birth

3
Subscribe